Sanchez-Madrid, Francisco,Alonso, Carlos Martinez,Madrid, David Sancho,Rocamora, Pablo Engel,Artola, Enric Esplugues,Ramos, Javier Vega,Gomez, Pilar Lauzurica
申请号：
AU2010241228
公开号：
AU2010241228B2
申请日:
2010.11.04
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
#$%^&*AU2010241228B220120913.pdf#####ABSTRACT Disclosed are methods of treating subjects having disorders or conditions characterized by an unwanted immune response including administering an effective amount of an early activation molecule agonist, antagonist or depletor, to the subject. Human monoclonal antibodies specific to the early activation molecules, and methods of use, are also disclosed.
